PSC
NBIX icon

Prentiss Smith & Co’s Neurocrine Biosciences NBIX Stock Holding History

Prentiss Smith & Co’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,763
Closed -$650K – 72
2024
Q4 		$650K Buy
+4,763
New +$650K 0.43% 48